Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion
about
Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusionConsecutive macular edema and visual outcome in branch retinal vein occlusion.Evaluating the impact of vitreomacular adhesion on anti-VEGF therapy for retinal vein occlusion using machine learningEfficacy of combined intravitreal bevacizumab and triamcinolone for branch retinal vein occlusion.Correlation between short- and long-term effects of intravitreal ranibizumab therapy on macular edema after branch retinal vein occlusion: a prospective observational study.Intravitreal bevacizumab treatment for macular edema due to branch retinal vein occlusion in a clinical setting.Postconditioning with inhaled carbon monoxide counteracts apoptosis and neuroinflammation in the ischemic rat retina.Functional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: a 6-month follow-up -- the SOLO study.Efficacy and safety of intravitreal therapy in macular edema due to branch and central retinal vein occlusion: a systematic review.Microaneurysms cause refractory macular edema in branch retinal vein occlusionA pharmacological approach in newly established retinal vein occlusion model.Comparison of immediate versus deferred intravitreal Bevacizumab in macular oedema due to branch retinal vein occlusion: a pilot study.Bevacizumab treatment for acute branch retinal vein occlusion accompanied by subretinal hemorrhage.Visual prognostic value of photopic negative response and optical coherence tomography in central retinal vein occlusion after anti-VEGF treatment.[Delayed treatment initiation of more than 2 weeks. Relevance for possible gain of visual acuity after anti-VEGF therapy under real life conditions (interim analysis of the prospective OCEAN study)].Natural Short-term Course of Recurrent Macular Edema Following Intravitreal Bevacizumab Therapy in Branch Retinal Vein Occlusion.Safety and efficacy of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in Chinese patients: randomized, sham-controlled, multicenter study.Predicting the visual acuity for retinal vein occlusion after ranibizumab therapy with an original ranking for macular microstructure.Predictive factors for recurrence of macular edema after successful intravitreal bevacizumab therapy in branch retinal vein occlusion.Efficacy of intravitreal bevacizumab for macular edema following branch retinal vein occlusion stratified by baseline visual acuity.Predictive factors for functional improvement following intravitreal bevacizumab injections after central retinal vein occlusion.Correlation between optical coherence tomographic hyperreflective foci and visual outcomes after intravitreal bevacizumab for macular edema in branch retinal vein occlusion.Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents for Ocular Vascular Diseases: Clinical Practice Guideline.Optical coherence tomography findings as a predictor of clinical course in patients with branch retinal vein occlusion treated with ranibizumab.Six-month results of intravitreal ranibizumab for macular edema after branch retinal vein occlusion in a single-center prospective study: visual outcomes and microaneurysm formation
P2860
Q24201821-5C18B17A-CE53-4A00-9256-A4B657A00CE6Q33748584-8EEA7167-CFBA-41D0-B5BC-66E2E1D3F330Q33774284-2FEC7424-F10F-42AA-AE34-79F1354F6EC6Q33780636-7EAA5EA4-5F6F-425B-94AF-F00C97B0CC05Q33795991-D1B2144D-E8D9-4BC1-A9B9-393168F4643CQ34293412-E95526DA-1187-4630-9596-D979E226ED20Q34431290-8E9C4812-6E88-4CD6-85C7-ADFAB14DB558Q34702859-95B3EF5B-D691-4786-8DA3-2FA17D18ED39Q35036495-C7D84173-BF60-4A3C-93A9-70FA827863A2Q36070623-26FB2539-6DCB-45FB-B8A9-0C6945F9DA1EQ36294951-03364340-13B4-40B7-9DB6-A7F2BE646203Q36354007-8FEB59A8-B102-49DF-A958-9ECA059EC383Q38261432-FC5054FE-F170-4868-A6C3-63609BD6A969Q38452392-AE711487-05AA-4552-899B-F9BDA38D3240Q41558337-61E896FD-A700-4B20-954F-6873B74B46D1Q42372246-A24F990A-D080-4DD2-8376-A03C892EAE4BQ49224656-5032A662-57A1-4279-B481-5C911A3D0F35Q49232014-E91E479B-9E6C-473E-82C3-1C3D9AFAFF6CQ50564863-DB3C6255-FDCB-4330-B6F3-6D8253D719E1Q51354430-EB00A6A1-017B-4B59-95C0-05BF7B1C9F1FQ51503406-36B53686-4381-4AE6-87C7-17A9100A32A6Q52648121-E8758457-88C2-4644-B39B-186C6321A17CQ54942391-C1FDE27F-E901-4596-A7D1-72F995F752E0Q55442786-FB701885-8E52-49E6-96D5-F4F119E85953Q58735740-77BA9828-C2A5-4362-9A1F-451420A60859
P2860
Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Predictive factors for functio ...... branch retinal vein occlusion
@ast
Predictive factors for functio ...... branch retinal vein occlusion
@en
Predictive factors for functio ...... branch retinal vein occlusion
@nl
type
label
Predictive factors for functio ...... branch retinal vein occlusion
@ast
Predictive factors for functio ...... branch retinal vein occlusion
@en
Predictive factors for functio ...... branch retinal vein occlusion
@nl
prefLabel
Predictive factors for functio ...... branch retinal vein occlusion
@ast
Predictive factors for functio ...... branch retinal vein occlusion
@en
Predictive factors for functio ...... branch retinal vein occlusion
@nl
P2093
P2860
P1476
Predictive factors for functio ...... branch retinal vein occlusion
@en
P2093
Carsten H Meyer
Georg Spital
Gesine B Jaissle
Heinrich Heimann
Matus Rehak
Nicolas Feltgen
Peter Szurman
Retinal Vein Occlusion Study Group
P2860
P2888
P304
P356
10.1007/S00417-010-1470-2
P577
2010-08-18T00:00:00Z
P5875
P6179
1016077133